SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Huser L, Sachindra S, Granados K, Federico A, Larribere L, Novak D, Umansky V, Altevogt P, Utikal J
Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.